Chemistry, mechanism and clinical status of antisense oligonucleotides and duplex RNAs

Xiulong Shen, David R. Corey

Research output: Contribution to journalArticle

95 Citations (Scopus)

Abstract

RNA plays a central role in the expression of all genes. Because any sequence within RNA can be recognized by complementary base pairing, synthetic oligonucleotides and oligonucleotide mimics offer a general strategy for controlling processes that affect disease. The two primary antisense approaches for regulating expression through recognition of cellular RNAs are single-stranded antisense oligonucleotides and duplex RNAs. This review will discuss the chemical modifications and molecular mechanisms that make synthetic nucleic acid drugs possible. Lessons learned from recent clinical trials will be summarized. Ongoing clinical trials are likely to decisively test the adequacy of our current generation of antisense nucleic acid technologies and highlight areas wheremore basic research is needed.

Original languageEnglish (US)
Pages (from-to)1584-1600
Number of pages17
JournalNucleic Acids Research
Volume46
Issue number4
DOIs
StatePublished - Feb 28 2018

Fingerprint

Antisense Oligonucleotides
RNA
Oligonucleotides
Nucleic Acids
Clinical Trials
Base Pairing
Technology
Gene Expression
Research
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Genetics

Cite this

Chemistry, mechanism and clinical status of antisense oligonucleotides and duplex RNAs. / Shen, Xiulong; Corey, David R.

In: Nucleic Acids Research, Vol. 46, No. 4, 28.02.2018, p. 1584-1600.

Research output: Contribution to journalArticle

@article{0ce2ac91d1144adfb3e8dd4bae994dbb,
title = "Chemistry, mechanism and clinical status of antisense oligonucleotides and duplex RNAs",
abstract = "RNA plays a central role in the expression of all genes. Because any sequence within RNA can be recognized by complementary base pairing, synthetic oligonucleotides and oligonucleotide mimics offer a general strategy for controlling processes that affect disease. The two primary antisense approaches for regulating expression through recognition of cellular RNAs are single-stranded antisense oligonucleotides and duplex RNAs. This review will discuss the chemical modifications and molecular mechanisms that make synthetic nucleic acid drugs possible. Lessons learned from recent clinical trials will be summarized. Ongoing clinical trials are likely to decisively test the adequacy of our current generation of antisense nucleic acid technologies and highlight areas wheremore basic research is needed.",
author = "Xiulong Shen and Corey, {David R.}",
year = "2018",
month = "2",
day = "28",
doi = "10.1093/nar/gkx1239",
language = "English (US)",
volume = "46",
pages = "1584--1600",
journal = "Nucleic Acids Research",
issn = "0305-1048",
publisher = "Oxford University Press",
number = "4",

}

TY - JOUR

T1 - Chemistry, mechanism and clinical status of antisense oligonucleotides and duplex RNAs

AU - Shen, Xiulong

AU - Corey, David R.

PY - 2018/2/28

Y1 - 2018/2/28

N2 - RNA plays a central role in the expression of all genes. Because any sequence within RNA can be recognized by complementary base pairing, synthetic oligonucleotides and oligonucleotide mimics offer a general strategy for controlling processes that affect disease. The two primary antisense approaches for regulating expression through recognition of cellular RNAs are single-stranded antisense oligonucleotides and duplex RNAs. This review will discuss the chemical modifications and molecular mechanisms that make synthetic nucleic acid drugs possible. Lessons learned from recent clinical trials will be summarized. Ongoing clinical trials are likely to decisively test the adequacy of our current generation of antisense nucleic acid technologies and highlight areas wheremore basic research is needed.

AB - RNA plays a central role in the expression of all genes. Because any sequence within RNA can be recognized by complementary base pairing, synthetic oligonucleotides and oligonucleotide mimics offer a general strategy for controlling processes that affect disease. The two primary antisense approaches for regulating expression through recognition of cellular RNAs are single-stranded antisense oligonucleotides and duplex RNAs. This review will discuss the chemical modifications and molecular mechanisms that make synthetic nucleic acid drugs possible. Lessons learned from recent clinical trials will be summarized. Ongoing clinical trials are likely to decisively test the adequacy of our current generation of antisense nucleic acid technologies and highlight areas wheremore basic research is needed.

UR - http://www.scopus.com/inward/record.url?scp=85041308609&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85041308609&partnerID=8YFLogxK

U2 - 10.1093/nar/gkx1239

DO - 10.1093/nar/gkx1239

M3 - Article

VL - 46

SP - 1584

EP - 1600

JO - Nucleic Acids Research

JF - Nucleic Acids Research

SN - 0305-1048

IS - 4

ER -